Tramadol and Cometriq drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tramadol (tramadol hydrochloride) and Cometriq (cabozantinib s-malate). Common drug interactions include odynophagia among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Tramadol and Cometriq. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.
What is Tramadol?
Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 235,800 Tramadol users. Check the latest studies of Tramadol.
What is Cometriq?
Cometriq has active ingredients of cabozantinib s-malate. eHealthMe is studying from 2,712 Cometriq users. Check the latest studies of Cometriq.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
76 people who take Tramadol and Cometriq together, and have interactions are studied.

What are the common drug interactions of Tramadol and Cometriq, by gender? *:
female:
- Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Dyspepsia (indigestion)
- Influenza
- Malignant neoplasm progression (cancer tumour came back)
- Drug intolerance (drug sensitivity)
- Muscle spasms (muscle contraction)
- Acne (skin problems that cause pimples)
- Aptyalism (deficiency or absence of saliva)
- Rash
male:
- Diarrhoea
- Fatigue (feeling of tiredness)
- Decreased appetite
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Headache (pain in head)
- Abdominal discomfort
- Asthenia (weakness)
- Bone pain
- Food intolerance (inability to have food)
- Glossodynia (a burning or painful sensation in the tongue)
What are the common drug interactions of Tramadol and Cometriq, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Malignant neoplasm progression (cancer tumour came back)
- Pericardial effusion malignant (cancerous fluid around the heart)
- Death
- Epistaxis (bleed from the nose)
- Nausea (feeling of having an urge to vomit)
- Rash
40-49:
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Fatigue (feeling of tiredness)
- Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
- Hair colour changes
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Sinusitis (inflammation of sinus)
- Stomatitis (inflammation of mucous membrane of mouth)
50-59:
- Decreased appetite
- Asthenia (weakness)
- Malignant neoplasm progression (cancer tumour came back)
- Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
- Stomatitis (inflammation of mucous membrane of mouth)
- Abdominal discomfort
- Diarrhoea
- Dysphagia (a condition in which swallowing is difficult or painful)
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Dyspnoea (difficult or laboured respiration)
60+:
- Diarrhoea
- Fatigue (feeling of tiredness)
- Asthenia (weakness)
- Bone pain
- Glossodynia (a burning or painful sensation in the tongue)
- Headache (pain in head)
- Myalgia (muscle pain)
- Oral discomfort (pain or irritation in mouth)
- Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
- Vomiting
What are the existing conditions these people have? *
- Thyroid Cancer: 50 people, 65.79%
- Renal Cell Carcinoma (a kidney cancer): 18 people, 23.68%
- Metastases To Lymph Nodes (cancer spreads to lymph node): 7 people, 9.21%
- Medullary Thyroid Cancer (type of thyroid cancer that develops in the parafollicular cells of the thyroid gland): 4 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Tramadol and Cometriq?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Tramadol and Cometriq:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tramadol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cometriq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tramadol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cometriq and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride and cabozantinib s-malate (the active ingredients of Tramadol and Cometriq, respectively), and Tramadol and Cometriq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Risperdal cause Skin Blushing/Flushing? - now
- Could Femara cause Synovitis? - a second ago
- Could Sitagliptin Phosphate cause Hypotension? - 2 seconds ago
- Could Xarelto cause Pulmonary Infarction? - 5 seconds ago
- Could Diazepam cause Refraction Disorder? - 5 seconds ago
- Could Micardis cause Mydriasis? - 7 seconds ago
- Could Namenda cause Faecal Incontinence? - 9 seconds ago
- Could Benicar cause Lung Neoplasm? - 12 seconds ago
- Could Lisinopril cause Angioedema? - 14 seconds ago
- Could Oxycodone cause Movement - Uncontrolled Or Slow? - 15 seconds ago